Global Virus Network (GVN) Adds Renowned Institut Pasteur Korea (IPK) to Combat Viral Diseases
Baltimore, Maryland, USA, March 22, 2021: The Global Virus Network (GVN), representing 62 Centers of Excellence and 11 Affiliates in 34 countries comprising foremost experts in every class of virus causing disease in humans, and the Institut Pasteur Korea (IPK) announced today the addition of the IPK as GVN’s newest Center of Excellence. “We are…
Pregnancy and COVID-19 Vaccines
Pregnancy and COVID-19 Vaccines March 5, 2021 While the COVID-19 vaccination program is extending globally, we have many questions regarding the vaccines’ safety, durability, and efficacy against variants. One of the important safety questions is the effects of COVID-19 vaccines on pregnant women as clinical trials for COVID-19 vaccines were conducted without their participation. Are…
Philanthropist Donates US$1 Million to Global Virus Network: Anonymous Gift Will Support Educational & Training Initiatives
Largest Gift In The Organization’s History Coincides With The Tenth Anniversary of the Founding of the Global Virus Network Baltimore, Maryland, USA, March 2, 2021: The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working to prevent illness and death from viral disease, today announced the donation of US$1…
Should the Global Community Be Concerned About the South African Variant?
Should the Global Community Be Concerned About the South African Variant? February 23, 2021 Currently, the downward trend of SARS-CoV-2 infections per day in the U.S. is continuing, and the case numbers of COVID-19 are less than half of what it was at the peak of the pandemic (Worldometers).The mortality rate of COVID-19 is also…
Global Virus Network Names USF Health the GVN Southeast U.S. Regional Headquarters
Baltimore, Maryland, USA (Feb. 23, 2021) — The Global Virus Network (GVN), a coalition comprising the world’s foremost experts in every class of virus causing disease in humans and some animals, today announced that USF Health, at the University of South Florida (USF) in Tampa, Fla., will serve as GVN’s Southeast United States Regional Headquarters. USF…
COVID-19 and Autoimmunity
COVID-19 and Autoimmunity Are Severe Cases of COVID-19 Related to an Autoimmune Disease? February 15, 2021 COVID-19, the disease caused by SARS-CoV-2, involves at least two distinct phases. The first phase is attributed to typical progress of respiratory disease by causing fever, cough, loss of taste/smell, and other symptoms typical of respiratory infections. The second…
Update on SARS-CoV-2 Variants
Update on SARS-CoV-2 Variants Efficient Vaccine Distribution is Critical to Mitigate the Continuing Evolution of SARS-CoV-2 February 5, 2021 We’ve recently reported on SARS-CoV-2 variants, and described some of the reasons for concern. These include increased transmissibility, the possibility of false negative tests for viral RNA, resistance to immune protection from vaccine or prior infection,…
GLOBAL VIRUS NETWORK (GVN) ADDS FOUR PREEMINENT ACADEMIC INSTITUTIONS TO STRENGTHEN GLOBAL COLLABORATION IN VIRAL RESEARCH AND RESPONSE TO PANDEMICS
The Four New GVN Members Form Three New Centers of Excellence and One Affiliate from Asia, the Caribbean, Europe and North America Baltimore, Maryland, USA, January 28, 2021: The Global Virus Network (GVN), comprising foremost experts around the world in every class of virus causing disease in humans and some animals, today announced the addition of three…
Emergence and Global Spread of SARS-CoV-2 Variants
Emergence and Global Spread of SARS-CoV-2 Variants With the extended COVID-19 pandemic, SARS-CoV-2 is evolving, and multiple COVID-19 variants are circulating globally. Since December, 2020, a great deal of attention has been focused on emergence of SARS-CoV-2 variants from the UK (VOC 202012/01; B1.1.7. lineage) and from South Africa (20C/501Y.V2; B.1.351 lineage). In the UK,…
A Statement from the Global Virus Network (GVN) on the Need for Innovative Strategies to Mitigate SARS-CoV-2 Variants and Expand Vaccination Strategies
Baltimore, Maryland, USA, January 15, 2021: As hospitalization and mortality from COVID-19 continue to surge around the world, it will be imperative to quickly distribute the vaccines that are proven to at least show short-term protection and overall safety. Combining vaccine distribution to protective measures (mask, physical distancing and hand washing) and novel approaches to treatment,…